Jessica Rexach is a Neurology physician affiliated with University of California, Los Angeles. OpenAlex indexes 58 publications with 2,231 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Ucla Medical Plz Ste B200
Los Angeles, CA 900951003
Telephone
310-794-1195Provider last certified this registry record 17 Jan 2020.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Cholinesterase Inhibitor56%Donepezil Hcl71%Rivastigmine29%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist29.3%Memantine Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
- Ultra High-Resolution Multimodal Cross-Disorder Atlas of Neurodegenerative Dementias
University of California Los Angeles
FY2026$674,513R01AG100878 - Hippocampal iPSC-Derived Assembloids to Model Interneuron and Circuit Vulnerability in Genetically-Encoded Amnestic and Behavioral Dementia
University of California Los Angeles
FY2025$3,109,857RF1NS144499 - Probing the Toxic Effects of Early Stage Tau Pathology on Microglial Modulation of Neuronal Circuits Using iPSC Hippocampal Assembloids
University of California Los Angeles
FY2024$433,125R21AG091113
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <i>BDNF</i> Val66Met polymorphism moderates associations between physical activity and neurocognitive outcomes in older adults
Alzheimer s & Dementia Translational Research & Clinical Interventions
2025 - An emergent disease-associated motor neuron state precedes cell death in a mouse model of ALS
bioRxiv (Cold Spring Harbor Laboratory)
2025 - Single‐nuclei transcriptomic identifies neuronal populations vulnerable to AD by leveraging AD variants
Alzheimer s & Dementia
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Jerome Engel, MD
University of California, Los Angeles
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”